Allurion Technologies (ALURD) EBITDA Margin (2022 - 2026)
Allurion Technologies' (ALURD) quarterly EBITDA Margin came in at 126.6% in Q1 2026, up 390.0% YoY from 25.84% in Q1 2025, and up 26.9% on a QoQ basis from 173.18% in Q4 2025.
Allurion Technologies (ALURD) EBITDA Margin (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of EBITDA Margin data on file, last reported at 126.6% in Q1 2026.
- Quarterly EBITDA Margin rose 390.0% year-over-year to 126.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 210.92% (down 4811.0% YoY) and the FY2025 annual result came in at 198.01%, down 4168.0% from the prior year.
- EBITDA Margin rose to 126.6% in Q1 2026, from 173.18% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 26.42% in Q2 2022 to a low of 362.3% in Q3 2025.
- A 5-year average of 159.17% and a median of 128.55% in 2026 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin tumbled 25965 bps — and 2025, when it soared 13294 bps.
- Tracing ALURD's EBITDA Margin over 5 years: stood at 52.9% in 2022, then slumped by 491 bps to 312.54% in 2023, then gained by 2 bps to 306.12% in 2024, then surged by 43 bps to 173.18% in 2025, then increased by 27 bps to 126.6% in 2026.
- The last three EBITDA Margin figures came in at 126.6% (Q1 2026), 173.18% (Q4 2025), and 362.3% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -126.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.60% |
| Dec 31, 2025 | -173.18% |
| Sep 30, 2025 | -362.30% |
| Jun 30, 2025 | -205.74% |
| Mar 31, 2025 | -130.50% |
| Dec 31, 2024 | -306.12% |
| Sep 30, 2024 | -229.94% |
| Jun 30, 2024 | -79.43% |
| Mar 31, 2024 | -121.35% |
| Dec 31, 2023 | -312.54% |
| Sep 30, 2023 | -143.70% |
| Jun 30, 2023 | -102.58% |
| Mar 31, 2023 | -98.78% |
| Dec 31, 2022 | -52.90% |
| Sep 30, 2022 | -74.61% |
| Jun 30, 2022 | -26.42% |